Dados B3 › LUPA3 × VAMO3
LUPA3 × VAMO3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | LUPA3 | VAMO3 | year |
|---|---|---|---|
| ROE | -56.5% | 0.0% | 2025 |
| ROIC | -14.4%! | 13.8% | 2025 |
| ROA | -12.2% | 1.5% | 2025 |
| Gross margin | 15.6% | 52.4% | 2025 |
| EBIT margin | -118.9%! | 45.4% | 2025 |
| Net margin | -115.6% | 5.7% | 2025 |
| Net debt/EBITDA | 5.50x | 3.53x | 2024 |
| Current ratio | 1.25x | 1.81x | 2025 |
| Revenue growth (1y) | -57.7% | 22.5% | 2025 |
| Revenue growth (5y CAGR) | -0.9% | 30.6% | 2025 |
| Piotroski F-Score | 3/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | LUPA3 | VAMO3 | year |
|---|---|---|---|
| P/E | -0.61x | — | 2025 |
| P/B | 0.50x | 1.55x | 2025 |
| EV/EBITDA | — | 4.37x | 2025 |
| FCF yield | 17.6% | -23.1% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:46 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:46 UTC. If this does not match /saude, you are reading a cached copy.